Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation-Reference-Cited by-同舟云学术

Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation

Published:2017-08 Issue:4 Volume:10 Page:
ISSN:1942-325X
Container-title:Circulation: Cardiovascular Genetics
language:en
Short-container-title:Circ Cardiovasc Genet

Author:

van Velzen Hannah G.¹,Schinkel Arend F.L.¹,Oldenburg Rogier A.¹,van Slegtenhorst Marjon A.¹,Frohn-Mulder Ingrid M.E.¹,van der Velden Jolanda¹,Michels Michelle¹

Affiliation:

1. From the Department of Cardiology, Thoraxcenter (H.G.v.V., A.F.L.S., M.M.), Department of Clinical Genetics (R.A.O., M.A.v.S.), and Department of Pediatrics (I.M.E.F.-M.), Erasmus Medical Center, Rotterdam, The Netherlands; Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands (J.v.d.V.); and Netherlands Heart Institute, Utrecht (J.v.d.V.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Genetics

Reference42 articles.

1. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy

2. Genetic advances in sarcomeric cardiomyopathies: state of the art

3. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands

4. Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands

5. Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study;Journal of Cardiovascular Translational Research;2024-08-19

2. Pharmacogenomics of coronary artery response to intravenous gamma globulin in kawasaki disease;npj Genomic Medicine;2024-05-30

3. Phenotypic spectrum of the first Belgian MYBPC3 founder: a large multi-exon deletion with a varying phenotype;Frontiers in Genetics;2024-05-21

4. Pharmacogenomics of Coronary Artery Response to Intravenous Gamma Globulin in Kawasaki Disease;2024-02-01

5. Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy;Circulation;2024-01-09